These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7284265)

  • 1. Inhibition of DNA replication and repair cultured humans cells by anthralin or danthron.
    Clark JM; Hanawalt PC
    Br J Dermatol; 1981 Aug; 105 Suppl 20():49-50. PubMed ID: 7284265
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of DNA replication and repair by anthralin or danthron in cultured human cells.
    Clark JM; Hanawalt PC
    J Invest Dermatol; 1982 Jul; 79(1):18-22. PubMed ID: 7086172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of UV-induced DNA repair at different steps by quinacrine and anthralin.
    Kulkarni MS; Yielding KL
    Biochem Biophys Res Commun; 1978 Aug; 83(4):1531-7. PubMed ID: 697879
    [No Abstract]   [Full Text] [Related]  

  • 4. Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytes.
    Reichert U; Jacques Y; Grangeret M; Schmidt R
    J Invest Dermatol; 1985 Feb; 84(2):130-4. PubMed ID: 2578530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonspecific inhibition of DNA repair synthesis by tumor promoters in human diploid fibroblasts damaged with N-acetoxy-2-acetylaminofluorene.
    Poirier MC; De Cicco BT; Lieberman MW
    Cancer Res; 1975 Jun; 35(6):1392-7. PubMed ID: 1131814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of mouse epidermal 12-lipoxygenase by anthralin--implications for the role of oxygen radicals.
    Müller K; Gawlik I
    Biochem Pharmacol; 1996 May; 51(9):1173-9. PubMed ID: 8645340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and tumor-promoting activity of analogues of anthralin (1,8-dihydroxy-9-anthrone).
    Van Duuren BL; Segal A; Tseng SS; Rusch GM; Loewengart G; Maté U; Roth D; Smith A; Melchionne S; Seidman I
    J Med Chem; 1978 Jan; 21(1):26-31. PubMed ID: 619147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthralin cytotoxicity.
    Dykes PJ; Roberts GP; Marks R
    Br J Dermatol; 1981 Aug; 105 Suppl 20():43-4. PubMed ID: 7284263
    [No Abstract]   [Full Text] [Related]  

  • 9. On the interaction between anthralin and DNA: a revision.
    Caron JC; Eustache J; Shroot B; Prota G
    Arch Dermatol Res; 1982; 274(3-4):207-12. PubMed ID: 7165372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of anthralin and analogues on growth and [3H] thymidine incorporation in human skin fibroblasts.
    Jacques Y; Reichert U
    Br J Dermatol; 1981 Aug; 105 Suppl 20():45-8. PubMed ID: 7284264
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of anthralin on mitochondrial and nuclear functions in yeast cells.
    Zetterberg G
    Br J Dermatol; 1981 Aug; 105 Suppl 20():39-42. PubMed ID: 7025882
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative effects of growth inhibitors on DNA replication, DNA repair, and protein synthesis in human epidermal keratinocytes.
    Bohr V; Mansbridge J; Hanawalt P
    Cancer Res; 1986 Jun; 46(6):2929-35. PubMed ID: 2421888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: anthralin--the challenge.
    Shroot B; Schaefer H; Juhlin L; Greaves MW
    Br J Dermatol; 1981 Aug; 105 Suppl 20():3-5. PubMed ID: 7284261
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of anthralin in mouse skin tumour promotion.
    Boutwell RK; Hoel MJ; Digiovanni J
    Br J Dermatol; 1981 Aug; 105 Suppl 20():68-9. PubMed ID: 7284270
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of anthralin (dithranol) on mitochondria.
    Morlière P; Dubertret L; Sa e Melo T; Salet C; Fosse M; Santus R
    Br J Dermatol; 1985 May; 112(5):509-15. PubMed ID: 4005152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of 3H-thymidine into DNA: inhibition by dithranol and its di- and triacetate.
    Plumier E; Wappes B; Wiegrebe W
    Arch Dermatol Res; 1984; 276(6):406-8. PubMed ID: 6517613
    [No Abstract]   [Full Text] [Related]  

  • 17. Anthralin.
    Shroot B
    Dermatologica; 1986; 173(6):261-3. PubMed ID: 3817237
    [No Abstract]   [Full Text] [Related]  

  • 18. The release and percutaneous permeation of anthralin products, using clinically involved and uninvolved psoriatic skin.
    Wang JC; Patel BG; Ehmann CW; Lowe N
    J Am Acad Dermatol; 1987 Apr; 16(4):812-21. PubMed ID: 3571544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthralin: chemical instability and glucose-6-phosphate dehydrogenase inhibition.
    Cavey D; Caron JC; Shroot B
    J Pharm Sci; 1982 Sep; 71(9):980-3. PubMed ID: 7131282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of anthralin and its derivatives on epidermal cell kinetics.
    Fisher LB; Maibach HI
    J Invest Dermatol; 1975 May; 64(5):338-41. PubMed ID: 1141709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.